Suppr超能文献

肝硬化腹水患者的巨噬细胞表现出宿主防御受体功能改变。

Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.

作者信息

Ahmed Abdel Motaal M, Kadaru Abdel Gadir Y, Omer Ibtihal, Musa Ahmed M, Enan Khalid, El Khidir Isam M, Williams Roger

机构信息

Department of Medicine, The National University for Medical and Allied Sciences, Khartoum 11123, Sudan.

Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum 11123, Sudan.

出版信息

J Clin Exp Hepatol. 2014 Dec;4(4):279-86. doi: 10.1016/j.jceh.2014.08.003. Epub 2014 Sep 16.

Abstract

BACKGROUND

Patients with cirrhotic ascites (PCA) are susceptible to spontaneous bacterial peritonitis (SBP) which has increased morbidity and mortality. Since some host defense aspects of peritoneal macrophages (PMф) from PCA are altered this study examined factors related to receptor-mediated phagocytosis.

METHODS

Twelve PCA were studied. PMɸ were isolated from ascitic fluid (AF) samples removed from these patients. Uptake of mannose receptor (MR)-specific ligand, fluorescein isothiocyanate-mannosylated-bovine serum albumin (FITC-man-BSA), by patients' PMɸ and controls, a human monocytic cell line, was measured pre- and post-IL-4 treatment. Phagocytosis of FITC-labeled yeast particles by patients' PMɸ was measured pre- and post-IL-4 treatment. Fluorescence values were obtained using a spectrofuorometer. MRC1 gene was analyzed in blood samples from PCA and controls, healthy donors, using standard polymerase chain reaction (PCR) technique.

RESULTS

Past SBP episode(s) were reported in 58.3% of patients. Mean AF volume analyzed per patient was 1.3L. PMɸ ratio in cell yield was 53.73% (SD 18.1). Mean uptake absorbance of patients' PMф was 0.0841 (SD 0.077) compared to 0.338 (SD 0.34) of controls, P = 0.023. Following IL-4 treatment absorbance increased to 0.297 (SD 0.28) in patients' PMф (P = 0.018 on paired sample t-test), and to 0.532 (SD 0.398 in controls (P = 0.053 on independent sample t-test). Mean phagocytosis absorbance of patients' PMф was 0.1250 (SD 0.032) before IL-4 treatment compared to 0.2300 (SD 0.104) after (P = 0.026). PCR analysis for MRC1 gene was negative in all PCA samples compared to positive results in all controls.

CONCLUSION

Since decreased phagocytosis and MR uptake were enhanced post-IL-4 treatment MR downregulation pre-treatment is plausible. Negative PCR results for MRC1 might suggest an anomaly, but this awaits further ellucidation. These altered host defense findings are relevant to infection pathophysiology, and their relevance to SBP susceptibility in PCA is worth verifying.

摘要

背景

肝硬化腹水(PCA)患者易发生自发性细菌性腹膜炎(SBP),其发病率和死亡率均有所增加。由于PCA患者腹膜巨噬细胞(PMф)的一些宿主防御方面发生了改变,本研究探讨了与受体介导的吞噬作用相关的因素。

方法

对12例PCA患者进行了研究。从这些患者抽取的腹水(AF)样本中分离出PMɸ。在白细胞介素-4(IL-4)处理前后,测量患者的PMɸ和作为对照的人单核细胞系对甘露糖受体(MR)特异性配体异硫氰酸荧光素-甘露糖化牛血清白蛋白(FITC-man-BSA)的摄取。在IL-4处理前后,测量患者的PMɸ对FITC标记的酵母颗粒的吞噬作用。使用荧光分光光度计获得荧光值。采用标准聚合酶链反应(PCR)技术,对PCA患者、对照者(健康供体)的血液样本中的MRC1基因进行分析。

结果

58.3%的患者报告有既往SBP发作史。每位患者分析的平均AF量为1.3L。细胞产量中的PMɸ比例为53.73%(标准差18.1)。患者PMф的平均摄取吸光度为0.0841(标准差0.077),而对照组为0.338(标准差0.34),P = 0.023。IL-4处理后,患者PMф中的吸光度增加至0.297(标准差0.28)(配对样本t检验,P = 0.018),对照组增加至0.532(标准差0.398)(独立样本t检验,P = 0.053)。IL-4处理前患者PMф的平均吞噬吸光度为0.1250(标准差0.032),处理后为0.2300(标准差0.104)(P = 0.026)。与所有对照结果均为阳性相比,所有PCA样本中MRC1基因的PCR分析均为阴性。

结论

由于IL-‑4处理后吞噬作用和MR摄取的降低得到增强,因此预处理时MR下调似乎是合理的。MRC1基因的PCR阴性结果可能提示存在异常,但这有待进一步阐明。这些宿主防御改变的发现与感染病理生理学相关,其与PCA患者SBP易感性的相关性值得验证。

相似文献

1
Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.
J Clin Exp Hepatol. 2014 Dec;4(4):279-86. doi: 10.1016/j.jceh.2014.08.003. Epub 2014 Sep 16.
2
Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality.
JHEP Rep. 2021 Nov 3;4(1):100391. doi: 10.1016/j.jhepr.2021.100391. eCollection 2022 Jan.
3
[Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].
Zhonghua Gan Zang Bing Za Zhi. 2019 Apr 20;27(4):274-280. doi: 10.3760/cma.j.issn.1007-3418.2019.04.007.
4
Bacteriologic study of cirrhotic patients with non-neutrocytic ascites.
Gastroenterol Hepatol Bed Bench. 2014 Fall;7(4):224-9.
5
Peritoneal macrophages from patients with cirrhotic ascites show impaired phagocytosis and vigorous respiratory burst.
Results Immunol. 2011 Sep 1;1(1):53-9. doi: 10.1016/j.rinim.2011.08.004. eCollection 2011.
6
Impaired innate immune response of leukocytes from ascitic fluid of patients with spontaneous bacterial peritonitis.
J Leukoc Biol. 2015 Nov;98(5):819-25. doi: 10.1189/jlb.3AB0315-106R. Epub 2015 Aug 7.
8
Schwann cells express the macrophage mannose receptor and MHC class II. Do they have a role in antigen presentation?
J Peripher Nerv Syst. 2009 Jun;14(2):84-92. doi: 10.1111/j.1529-8027.2009.00217.x.

引用本文的文献

1
Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution.
Immunity. 2017 Jan 17;46(1):92-105. doi: 10.1016/j.immuni.2016.12.009. Epub 2017 Jan 5.

本文引用的文献

1
Peritoneal macrophages from patients with cirrhotic ascites show impaired phagocytosis and vigorous respiratory burst.
Results Immunol. 2011 Sep 1;1(1):53-9. doi: 10.1016/j.rinim.2011.08.004. eCollection 2011.
2
Polymorphic allele of human MRC1 confer protection against tuberculosis in a Chinese population.
Int J Biol Sci. 2012;8(3):375-82. doi: 10.7150/ijbs.4047. Epub 2012 Feb 23.
3
Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility.
Hum Genet. 2010 Mar;127(3):337-48. doi: 10.1007/s00439-009-0775-x. Epub 2009 Dec 25.
4
Management of adult patients with ascites due to cirrhosis: an update.
Hepatology. 2009 Jun;49(6):2087-107. doi: 10.1002/hep.22853.
5
Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2008 Jul 15;178(2):139-48. doi: 10.1164/rccm.200711-1666OC. Epub 2008 Apr 17.
6
Spontaneous bacterial peritonitis.
Dig Dis. 2005;23(1):39-46. doi: 10.1159/000084724.
7
Spontaneous bacterial peritonitis: recent data on incidence and treatment.
Cleve Clin J Med. 2004 Jul;71(7):569-76. doi: 10.3949/ccjm.71.7.569.
9
THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.
J Exp Med. 1964 Jul 1;120(1):105-20. doi: 10.1084/jem.120.1.105.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验